{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:18:39Z","timestamp":1792275519905,"version":"4.4.0"},"publisher-location":"New York, NY","reference-count":142,"publisher":"Springer New York","isbn-type":[{"value":"9781441915986","type":"print"},{"value":"9781441915993","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-1-4419-1599-3_2","type":"book-chapter","created":{"date-parts":[[2010,7,28]],"date-time":"2010-07-28T23:00:11Z","timestamp":1280358011000},"page":"17-29","source":"Crossref","is-referenced-by-count":101,"title":["FOXP3 and Its Role in the Immune System"],"prefix":"10.1007","author":[{"given":"Chang H.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"2_CR1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10549-007-9812-4","volume":"111","author":"G.J. Bates","year":"2008","unstructured":"Bates GJ, Fox SB, Han C et al. Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasivebreast carcinomas. Breast Cancer Res Treat 2008; 111:453\u2013459.","journal-title":"Breast Cancer Res Treat"},{"key":"2_CR2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nri2061","volume":"7","author":"D.J. Campbell","year":"2007","unstructured":"Campbell DJ, Ziegler SF. FOXP3 modifies the phenotypic and functional properties of regulatory T-cells. Nat Rev Immunol 2007; 7:305\u2013310.","journal-title":"Nat Rev Immunol"},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.0105-2896.2006.00415.x","volume":"212","author":"E.M. Shevach","year":"2006","unstructured":"Shevach EM, DiPaolo RA, Andersson J et al. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T-cells. Immunol Rev 2006; 212:60\u201373.","journal-title":"Immunol Rev"},{"key":"2_CR4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.immunol.24.021605.090547","volume":"24","author":"S.F. Ziegler","year":"2006","unstructured":"Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol 2006; 24:209\u2013226.","journal-title":"Annu Rev Immunol"},{"key":"2_CR5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2174\/138955707782331731","volume":"7","author":"C.H. Kim","year":"2007","unstructured":"Kim CH. Molecular targets of FoxP3+ regulatory T-cells. Mini Rev Med Chern 2007; 7:1136\u20131143.","journal-title":"Mini Rev Med Chern"},{"key":"2_CR6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","volume":"212","author":"S. Sakaguchi","year":"2006","unstructured":"Sakaguchi S, Ono M, Setoguchi R et al. Foxp3+ CD25+ CD4+ natural regulatory T-cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006; 212:8\u201327.","journal-title":"Immunol Rev"},{"key":"2_CR7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","volume":"6","author":"S. Sakaguchi","year":"2005","unstructured":"Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T-cells in immunological tolerance to self and nonself. Nat Immunol 2005; 6:345\u2013352.","journal-title":"Nat Immunol"},{"key":"2_CR8","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood-2006-02-002774","volume":"108","author":"M. Beyer","year":"2006","unstructured":"Beyer M, Schultze JL. Regulatory T-cells in cancer. Blood 2006; 108:804\u2013811.","journal-title":"Blood"},{"key":"2_CR9","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.20050157","volume":"2002","author":"X. Chang","year":"2005","unstructured":"Chang X, Gao JX, Jiang Q et al. The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thyrnopoiesis. J Exp Med 2005; 2002:1141\u20131151.","journal-title":"J Exp Med"},{"key":"2_CR10","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.cell.2007.04.034","volume":"129","author":"T. Zuo","year":"2007","unstructured":"Zuo T, Wang L, Morrison C et al. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2\/ErbB2 oncogene. Cell 2007; 129:1275\u20131286.","journal-title":"Cell"},{"key":"2_CR11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1086\/302761","volume":"66","author":"C.L. Bennett","year":"2000","unstructured":"Bennett CL, Yoshioka R, Kiyosawa H et al. X-Linked syndrome of polyendocrinopathy, immune dysfunction and diarrhea maps to Xp11.23\u2013Xq13.3. Am J Hum Genet 2000; 66:461\u2013468.","journal-title":"Am J Hum Genet"},{"key":"2_CR12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","volume":"27","author":"C.L. Bennett","year":"2001","unstructured":"Bennett CL, Christie J, Ramsdell F et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27:20\u201321.","journal-title":"Nat Genet"},{"key":"2_CR13","first-page":"239","volume":"248","author":"E. Kaufmann","year":"1995","unstructured":"Kaufmann E, Muller D, Knochel W. DNA recognition site analysis of Xenopus winged helix proteins. J Mol Biol 1995; 248:239\u2013254.","journal-title":"J Mol Biol"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"37672","DOI":"10.1074\/jbc.M104521200","volume":"276","author":"L.A. Schubert","year":"2001","unstructured":"Schubert LA, Jeffery E, Zhang Y et al. Scurfin (FOXP3) acts as a repressor of transcription and regulates T-cell activation. J Biol Chem 2001; 276:37672\u201337679.","journal-title":"J Biol Chem"},{"key":"2_CR15","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.4049\/jimmunol.177.5.3133","volume":"177","author":"J.E. Lopes","year":"2006","unstructured":"Lopes JE, Torgerson TR, Schubert LA et al. Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J Immunol 2006; 177:3133\u20133142.","journal-title":"J Immunol"},{"key":"2_CR16","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1073\/pnas.0501675102","volume":"102","author":"E. Bettelli","year":"2005","unstructured":"Bettelli E, Dastrange M, Oukka M. FOXP3 interacts with nuclear factor of activated T-cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci USA 2005; 102:5138\u20135143.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1006\/viro.1996.0071","volume":"216","author":"J. Kamine","year":"1996","unstructured":"Kamine J, Elangovan B, Subramanian T et al. Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. Virology 1996; 216:357\u2013366.","journal-title":"Virology"},{"key":"2_CR18","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/nar\/gkh252","volume":"32","author":"X.J. Yang","year":"2004","unstructured":"Yang XJ. The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res 2004; 32:959\u2013976.","journal-title":"Nucleic Acids Res"},{"key":"2_CR19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00008480-200112000-00007","volume":"13","author":"C.L. Bennett","year":"2001","unstructured":"Bennett CL, Ochs HD. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy and a variety of autoimmune phenomena. Curr Opin Pediatr 2001; 13:533\u2013538.","journal-title":"Curr Opin Pediatr"},{"key":"2_CR20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12026-007-0022-2","volume":"38","author":"H.D. Ochs","year":"2007","unstructured":"Ochs HD, Gambineri E, Torgerson TR. IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Immunol Res 2007; 38:112\u2013121.","journal-title":"Immunol Res"},{"key":"2_CR21","first-page":"89017","volume":"2007","author":"H.J. Vliet van der","year":"2007","unstructured":"van der Vliet HJ, Nieuwenhuis EE. IPEX as a result of mutations in FOXP3. Clin Dev Immunol 2007; 2007:89017.","journal-title":"Clin Dev Immunol"},{"key":"2_CR22","doi-asserted-by":"crossref","first-page":"36828","DOI":"10.1074\/jbc.M608848200","volume":"281","author":"C. Chen","year":"2006","unstructured":"Chen, C, Rowell EA, Thomas RM et al. Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J Biol Chem 2006; 281:36828\u201336834.","journal-title":"J Biol Chem"},{"key":"2_CR23","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nature05563","volume":"445","author":"Y. Zheng","year":"2007","unstructured":"Zheng Y, Josefowicz SZ, Kas A et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T-cells. Nature 2007; 445:936\u2013940.","journal-title":"Nature"},{"key":"2_CR24","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature05478","volume":"445","author":"A. Marson","year":"2007","unstructured":"Marson A, Kretschmer K, Frampton GM et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007; 445:931\u2013935.","journal-title":"Nature"},{"key":"2_CR25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2006.05.042","volume":"126","author":"Y. Wu","year":"2006","unstructured":"Wu Y, Borde M, Heissmeyer V et al. FOXP3 controls regulatory T-cell function through cooperation with NFAT. Cell 2006; 126:375\u2013387.","journal-title":"Cell"},{"key":"2_CR26","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.exphem.2006.03.014","volume":"34","author":"C.H. Kim","year":"2006","unstructured":"Kim CH. Migration and function of FoxP3+ regulatory T-cells in the hematolyrnphoid system. Exp Hematol 2006; 34:1033\u20131040.","journal-title":"Exp Hematol"},{"key":"2_CR27","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.4049\/jimmunol.176.6.3593","volume":"176","author":"P.Y. Mantel","year":"2006","unstructured":"Mantel PY, Ouaked N, Ruckert B et al. Molecular mechanisms underlying FOXP3 induction in human T-cells. J Immunol 2006; 176:3593\u20133602.","journal-title":"J Immunol"},{"key":"2_CR28","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1172\/JCI23961","volume":"115","author":"B. Bisikirska","year":"2005","unstructured":"Bisikirska B, Colgan J, Luban J et al. TCR stimulation with modified anti-CD3 mAb expands CD8+ T-cell population and induces CD8+CD25+ Tregs. J Clin Invest 2005; 115:2904\u20132913.","journal-title":"J Clin Invest"},{"key":"2_CR29","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1084\/jem.20050784","volume":"2002","author":"J.D. Fontenot","year":"2005","unstructured":"Fontenot JD, Dooley JL, Farr AG et al. Developmental regulation of Foxp3 expression during ontogeny. J Exp Med 2005; 2002:901\u2013906.","journal-title":"J Exp Med"},{"key":"2_CR30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00005-007-0024-8","volume":"55","author":"C.H. Kim","year":"2007","unstructured":"Kim CH. Trafficking of FoxP3+ regulatory T-cells: myths and facts. Arch Immunol Ther Exp (Warsz) 2007; 55:151\u2013159.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"2_CR31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4049\/jimmunol.178.1.301","volume":"178","author":"J.H. Lee","year":"2007","unstructured":"Lee JH, Kang SG, Kim CH. FoxP3+ T-cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. J Immunol 2007; 178:301\u2013311.","journal-title":"J Immunol"},{"key":"2_CR32","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.4049\/jimmunol.180.6.3651","volume":"180","author":"H. Tuovinen","year":"2008","unstructured":"Tuovinen H, Kekalainen E, Rossi LH et al. Cutting edge: human CD4-CD8-thyrnocytes express FOXP3 in the absence of a TCR. J Immunol 2008; 180:3651\u20133654.","journal-title":"J Immunol"},{"key":"2_CR33","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S. Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S. Control of regulatory T-cell development by the transcription factor Foxp3. Science 2003; 299:1057\u20131061.","journal-title":"Science"},{"key":"2_CR34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","volume":"4","author":"R. Khattri","year":"2003","unstructured":"Khattri R, Cox T, Yasayko SA et al. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003; 4:337\u2013342.","journal-title":"Nat Immunol"},{"key":"2_CR35","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1172\/JCI24685","volume":"115","author":"S.E. Allan","year":"2005","unstructured":"Allan SE, Passerini L, Bacchetta R et al. The role of 2 FOXP3 isoforms in the generation of human CD4 Tregs. J Clin Invest 2005; 115:3276\u20133284.","journal-title":"J Clin Invest"},{"key":"2_CR36","doi-asserted-by":"crossref","first-page":"7797","DOI":"10.1073\/pnas.0800928105","volume":"105","author":"S. Sauer","year":"2008","unstructured":"Sauer S, Bruno L, Hertweck A et al. T-cell receptor signaling controls Foxp3 expression via PI3K, Akt and mTOR. Proc Natl Acad Sci USA 2008; 105:7797\u20137802.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR37","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood-2006-02-004747","volume":"108","author":"E. Zorn","year":"2006","unstructured":"Zorn E, Nelson EA, Mohseni M et al. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T-cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 2006; 108:1571\u20131579.","journal-title":"Blood"},{"key":"2_CR38","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pbio.0050038","volume":"5","author":"S. Floess","year":"2007","unstructured":"Floess S, Freyer J, Siewert C et al. Epigenetic control of the foxp3 locus in regulatory T-cells. PLoS Biol 2007; 5:e38.","journal-title":"PLoS Biol"},{"key":"2_CR39","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1084\/jem.20070109","volume":"204","author":"H.P. Kim","year":"2007","unstructured":"Kim HP, Leonard WJ. CREB\/ATF-dependent T-cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med 2007; 204:1543\u20131551.","journal-title":"J Exp Med"},{"key":"2_CR40","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","volume":"198","author":"W. Chen","year":"2003","unstructured":"Chen W, Jin W, Hardegen N et al. Conversion of peripheral CD4+CD25\u2212 naive T-cells to CD4+CD25+ regulatory T-cells by TGF-beta induction oftranscription factor Foxp3. J Exp Med 2003; 198:1875\u20131886.","journal-title":"J Exp Med"},{"key":"2_CR41","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.4049\/jimmunol.172.9.5149","volume":"172","author":"M.C. Fantini","year":"2004","unstructured":"Fantini MC, Becker C, Monteleone G et al. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25\u2212 T-cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004; 172:5149\u20135153.","journal-title":"J Immunol"},{"key":"2_CR42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ni1549","volume":"9","author":"Y. Tone","year":"2008","unstructured":"Tone Y, Furuuchi K, Kojima Y et al. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 2008; 9:194\u2013202.","journal-title":"Nat Immunol"},{"key":"2_CR43","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/eji.200737594","volume":"37","author":"U. Baron","year":"2007","unstructured":"Baron U, Floess S, Wieczorek G et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T-cells from activated FOXP3(+) conventional T-cells. Eur J Immunol 2007; 37:2378\u20132389.","journal-title":"Eur J Immunol"},{"key":"2_CR44","doi-asserted-by":"crossref","first-page":"e1612","DOI":"10.1371\/journal.pone.0001612","volume":"3","author":"P.C. Janson","year":"2008","unstructured":"Janson PC, Winerdal ME, Marits P et al. FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS ONE 2008; 3:e1612.","journal-title":"PLoS ONE"},{"key":"2_CR45","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/eji.200838105","volume":"38","author":"J.K. Polansky","year":"2008","unstructured":"Polansky JK, Kretschmer K, Freyer J et al. DNA methylation controls Foxp3 gene expression. Eur J Immunol 2008; 38:1654\u20131663.","journal-title":"Eur J Immunol"},{"key":"2_CR46","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1182\/blood-2006-11-055756","volume":"109","author":"Z. Yao","year":"2007","unstructured":"Yao Z, Kanno Y, Kerenyi M et al. Nonredundant roles for Stat5a\/b in directly regulating Foxp3. Blood 2007; 109:4368\u20134375.","journal-title":"Blood"},{"key":"2_CR47","doi-asserted-by":"crossref","first-page":"14955","DOI":"10.1074\/jbc.M801123200","volume":"283","author":"H. Takaki","year":"2008","unstructured":"Takaki H, Ichiyama K, Koga K et al. STAT6 Inhibits TGF-betal-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor. J Biol Chem 2008; 283:14955\u201314962.","journal-title":"J Biol Chem"},{"key":"2_CR48","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/intimm\/dxm045","volume":"19","author":"M. Nishihara","year":"2007","unstructured":"Nishihara M, Ogura H, Ueda N et al. IL-6-gp130-STAT3 in T-cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. Int Immunol 2007; 19:695\u2013702.","journal-title":"Int Immunol"},{"key":"2_CR49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","volume":"24","author":"M. Veldhoen","year":"2006","unstructured":"Veldhoen M, Hocking RJ, Atkins CJ et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T-cells. Immunity 2006; 24:179\u2013189.","journal-title":"Immunity"},{"key":"2_CR50","doi-asserted-by":"crossref","first-page":"14023","DOI":"10.1073\/pnas.0806726105","volume":"105","author":"A. Samanta","year":"2008","unstructured":"Samanta A, Li B, Song X et al. TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3. Proc Natl Acad Sci USA 2008; 105:14023\u201314027.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR51","first-page":"1688","volume":"143","author":"S.A. Michie","year":"1993","unstructured":"Michie SA, Streeter PR, Bolt PA et al. The human peripheral lymph node vascular addressin. An inducible endothelial antigen involved in lymphocyte homing. Am J Pathol 1993; 143:1688\u20131698.","journal-title":"Am J Pathol"},{"key":"2_CR52","first-page":"1053","volume":"136","author":"L.J. Picker","year":"1990","unstructured":"Picker LJ, Michie SA, Rott LS et al. A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T-cells at cutaneous sites. Am J Pathol 1990; 136:1053\u20131068.","journal-title":"Am J Pathol"},{"key":"2_CR53","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1083\/jcb.107.5.1853","volume":"107","author":"P.R. Streeter","year":"1988","unstructured":"Streeter PR, Rouse BT, Butcher EC. Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J Cell Biol 1988; 107:1853\u20131862.","journal-title":"J Cell Biol"},{"key":"2_CR54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","volume":"99","author":"R. Forster","year":"1999","unstructured":"Forster R, Schubel A, Breitfeld D et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999; 99:23\u201333.","journal-title":"Cell"},{"key":"2_CR55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1084\/jem.191.1.61","volume":"191","author":"J.V. Stein","year":"2000","unstructured":"Stein JV, Rot A, Luo Y et al. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T-Iymphocytes in peripheral lymph node high endothelial venules. J Exp Med 2000; 191:61\u201376.","journal-title":"J Exp Med"},{"key":"2_CR56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1084\/jem.191.1.77","volume":"191","author":"R.A. Warnock","year":"2000","unstructured":"Warnock RA, Campbell JJ, Dorf ME et al. The role of chemokines in the microenvironmental control of T versus B-cell arrest in Peyer\u2019s patch high endothelial venules. J Exp Med 2000; 191:77\u201388.","journal-title":"J Exp Med"},{"key":"2_CR57","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.4049\/jimmunol.178.12.7598","volume":"178","author":"M.A. Wurbel","year":"2007","unstructured":"Wurbel MA, Malissen M, Guy-Grand D et al. Impaired accumulation of antigen-specific CD8 lymphocytes in chemokine CCL25-deficient intestinal epithelium and lamina propria. J Immunol 2007; 178:7598\u20137606.","journal-title":"J Immunol"},{"key":"2_CR58","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1073\/pnas.0609180104","volume":"104","author":"M. Wendland","year":"2007","unstructured":"Wendland M, Czeloth N, Mach N et al. CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proc Natl Acad Sci USA 2007; 104:6347\u20136352.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR59","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2005-07-2860","volume":"107","author":"H. Stenstad","year":"2006","unstructured":"Stenstad H, Ericsson A, Johansson-Lindborn B et al. Gut-associated lymphoid tissue-primed CD4+ T-cells display CCR9-dependent and-independent homing to the small intestine. Blood 2006; 107:3447\u20133454.","journal-title":"Blood"},{"key":"2_CR60","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.4049\/jimmunol.165.9.5069","volume":"165","author":"K.A. Papadakis","year":"2000","unstructured":"Papadakis KA, Prehn J, Nelson V et al. The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J Immunol 2000; 165:5069\u20135076.","journal-title":"J Immunol"},{"key":"2_CR61","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1084\/jem.192.5.761","volume":"192","author":"E.J. Kunkel","year":"2000","unstructured":"Kunkel EJ, Campbell JJ, Haraldsen G et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med 2000; 192:761\u2013768.","journal-title":"J Exp Med"},{"key":"2_CR62","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.4049\/jimmunol.152.7.3282","volume":"152","author":"A. Hamann","year":"1994","unstructured":"Hamann A, Andrew DP, Jablonski-Westrich D et al. Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo. J Immunol 1994; 152:3282\u20133293.","journal-title":"J Immunol"},{"key":"2_CR63","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(93)90305-A","volume":"74","author":"C. Berlin","year":"1993","unstructured":"Berlin C, Berg EL, Briskin MJ et al. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993; 74:185\u2013185.","journal-title":"Cell"},{"key":"2_CR64","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1172\/JCI200422325","volume":"114","author":"H.W. Lim","year":"2004","unstructured":"Lim HW, Hillsamer P, Kim CH. Regulatory T-cells can migrate to follicles upon T-cell activation and suppress GC-Th cells and GC-Th cell-driven B-cell responses. J Clin Invest 2004; 114:1640\u20131649.","journal-title":"J Clin Invest"},{"key":"2_CR65","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.20031562","volume":"199","author":"J. Huehn","year":"2004","unstructured":"Huehn J, Siegmund K, Lehmann JC et al. Developmental Stage, Phenotype and Migration Distinguish Naive-and Effector\/Memory-like CD4+ Regulatory T-Cells. J Exp Med 2004; 199:303\u2013313.","journal-title":"J Exp Med"},{"key":"2_CR66","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.20041709","volume":"201","author":"I. Lee","year":"2005","unstructured":"Lee I, Wang L, Wells AD et al. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 2005; 201:1037\u20131044.","journal-title":"J Exp Med"},{"key":"2_CR67","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1084\/jem.20070081","volume":"204","author":"B.D. Sather","year":"2007","unstructured":"Sather BD, Treuting P, Perdue N et al. Altering the distribution of Foxp3(+) regulatory T-cells results in tissue-specific inflammatory disease. J Exp Med 2007; 204:1335\u20131347.","journal-title":"J Exp Med"},{"key":"2_CR68","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1084\/jem.20061405","volume":"204","author":"M.A. Schneider","year":"2007","unstructured":"Schneider MA, Meingassner JG, Lipp M et al. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T-cells. J Exp Med 2007; 204:735\u2013745.","journal-title":"J Exp Med"},{"key":"2_CR69","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1145697","volume":"317","author":"D. Mucida","year":"2007","unstructured":"Mucida D, Park Y, Kim G et al. Reciprocal TH17 and regulatory T-cell differentiation mediated by retinoic acid. Science 2007; 317:256\u2013260.","journal-title":"Science"},{"key":"2_CR70","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1084\/jem.20070719","volume":"204","author":"M.J. Benson","year":"2007","unstructured":"Benson MJ, Pino-Lagos K, Rosemblatt M et al. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation and gut homing in the face of high levels of costimulation. J Exp Med 2007; 204:1765\u20131774.","journal-title":"J Exp Med"},{"key":"2_CR71","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1084\/jem.20070602","volume":"204","author":"C.M. Sun","year":"2007","unstructured":"Sun CM, Hall JA, Blank RB et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007; 204: 1775\u20131785.","journal-title":"J Exp Med"},{"key":"2_CR72","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1084\/jem.20070590","volume":"204","author":"J.L. Coombes","year":"2007","unstructured":"Coombes JL, Siddiqui KR, Arancibia-Carcamo CV et al. A functionally specialized population of mucosal CDI03+ DCs induces Foxp3+ regulatory T-cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 2007; 204:1757\u20131764.","journal-title":"J Exp Med"},{"key":"2_CR73","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.4049\/jimmunol.179.6.3724","volume":"179","author":"S.G. Kang","year":"2007","unstructured":"Kang SG, Lim HW, Andrisani OM et al. Vitamin A Metabolites Induce Gut-Homing FoxP3+ Regulatory T-Cells. J Immunol 2007; 179:3724\u20133733.","journal-title":"J Immunol"},{"key":"2_CR74","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1002\/eji.200737621","volume":"37","author":"F. Schambach","year":"2007","unstructured":"Schambach F, Schupp M, Lazar MA et al. Activation of retinoic acid receptor-alpha favours regulatory T-cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur J Immunol 2007; 37:2396\u20132399.","journal-title":"Eur J Immunol"},{"key":"2_CR75","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood-2007-06-096438","volume":"111","author":"K.M. Elias","year":"2008","unstructured":"Elias KM, Laurence A, Davidson TS et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3\/ Stat-5 independent signaling pathway. Blood 2008; 111:1013\u20131020.","journal-title":"Blood"},{"key":"2_CR76","first-page":"416910","volume":"2008","author":"C.H. Kim","year":"2008","unstructured":"Kim CH. Regulation of FoxP3 regulatory T-cells and Th17 cells by retinoids. Clin Dev Immunol 2008; 2008:416910.","journal-title":"Clin Dev Immunol"},{"key":"2_CR77","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/j.gastro.2007.01.008","volume":"132","author":"S.G. Kang","year":"2007","unstructured":"Kang SG, Piniecki RJ, Hogenesch H et al. Identification of a chemokine network that recruits FoxP3(+) regulatory T-cells into chronically inAamed intestine. Gastroenterology 2007; 132:966\u2013981.","journal-title":"Gastroenterology"},{"key":"2_CR78","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2004.08.011","volume":"21","author":"M. Iwata","year":"2004","unstructured":"Iwata M, Hirakiyama A, Eshima Y et al. Retinoic acid imprints gut-homing specificity on T-cells. Immunity 2004; 21:527\u2013538.","journal-title":"Immunity"},{"key":"2_CR79","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","volume":"369","author":"D.C. Baumgart","year":"2007","unstructured":"Baumgart DC, Carding SR. In Aammatory bowel disease: cause and immunobiology. Lancet 2007; 369:1627\u20131640.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"2_CR80","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.MIB.0000195385.19268.68","volume":"12","author":"S.B. Hanauer","year":"2006","unstructured":"Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis and therapeutic opportunities. In Aamm Bowel Dis 2006; (12 Suppl 1):S3\u20139.","journal-title":"In Aamm Bowel Dis"},{"key":"2_CR81","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.4049\/jimmunol.181.4.2277","volume":"181","author":"S. Xiao","year":"2008","unstructured":"Xiao S, Jin H, Korn T et al. Retinoic acid increases Foxp3+ regulatory T-cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 2008; 181:2277\u20132284.","journal-title":"J Immunol"},{"key":"2_CR82","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.4049\/jimmunol.174.9.5444","volume":"174","author":"I. Suffia","year":"2005","unstructured":"Suffia I, Reclding SK, Salay G et al. A role for CD 103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J Immunol 2005; 174:5444\u20135455.","journal-title":"J Immunol"},{"key":"2_CR83","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1084\/jem.20040662","volume":"202","author":"O. Annacker","year":"2005","unstructured":"Annacker O, Coombes JL, Malmstrom V et al. Essential role for CDI03 in the T-cell-mediated regulation of experimental colitis. J Exp Med 2005; 202:1051\u20131061.","journal-title":"J Exp Med"},{"key":"2_CR84","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2004-05-2044","volume":"105","author":"J. Ermann","year":"2005","unstructured":"Ermann J, Hoffmann P, Edinger M et al. Only the CD62L+ subpopulation ofCD4+CD25+ regulatory T-cells protects from lethal acute GVHD. Blood 2005; 105:2220\u20132226.","journal-title":"Blood"},{"key":"2_CR85","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/blood-2004-05-1850","volume":"104","author":"P.A. Taylor","year":"2004","unstructured":"Taylor PA, Panoskalrsis-Mortari A, Swedin JM et al. L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 2004; 104:3804\u20133812.","journal-title":"Blood"},{"key":"2_CR86","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1084\/jem.194.5.629","volume":"194","author":"K. Nakamura","year":"2001","unstructured":"Nakamura K, Kitani A, Strober W Cell contact-dependent immuno suppression by CD4(+)CD25(+) regulatory T-cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001; 194:629\u2013644.","journal-title":"J Exp Med"},{"key":"2_CR87","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1084\/jem.20020590","volume":"196","author":"C.A. Piccirillo","year":"2002","unstructured":"Piccirillo CA, Letterio JJ, Thornton AM et al. CD4(+)CD25(+) regulatory T-cells can mediate suppressor function in the absence of transforming growth factor beta I production and responsiveness. J Exp Med 2002; 196:237\u2013246.","journal-title":"J Exp Med"},{"key":"2_CR88","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1182\/blood-2003-08-2897","volume":"103","author":"M. Mamura","year":"2004","unstructured":"Mamura M, Lee W, Sullivan TJ et al. CD28 disruption exacerbates in Aammation in Tgf-betal-\/-mice: in vivo suppression by CD4+CD25+ regulatory T-cells independent of autocrine TGF-beta1. Blood 2004; 103:4594\u20134601.","journal-title":"Blood"},{"key":"2_CR89","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.4049\/jimmunol.173.11.6526","volume":"173","author":"S. Huber","year":"2004","unstructured":"Huber S, Schramm C, Lehr HA et al. Cutting edge: TGF-beta signaling is required for the in vivo expansion and immuno suppressive capacity of regulatory CD4+CD25+ T-cells. J Immunol 2004; 173:6526\u20136531.","journal-title":"J Immunol"},{"key":"2_CR90","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4049\/jimmunol.172.2.834","volume":"172","author":"K. Nakamura","year":"2004","unstructured":"Nakamura K, Kitani A, Fuss I et al. TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T-cell activity in both humans and mice. J Immunol 2004; 172:834\u2013842.","journal-title":"J Immunol"},{"key":"2_CR91","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/eji.200526106","volume":"35","author":"M.C. Kullberg","year":"2005","unstructured":"Kullberg MC, Hay V, Cheever AW et al. TGF-beta1 production by CD4+ CD25+ regulatory T-cells is not essential for suppression of intestinal inflammation. Eur J Immunol 2005; 35:2886\u20132895.","journal-title":"Eur J Immunol"},{"key":"2_CR92","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.20020110","volume":"196","author":"F. Annunziato","year":"2002","unstructured":"Annunziato F, Cosmi L, Liotta F et al. Phenotype, localization and mechanism of suppressionof CD4(+) CD25(+) human thymocytes. J Exp Med 2002; 196:379\u2013387.","journal-title":"J Exp Med"},{"key":"2_CR93","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1002\/1521-4141(2002010)32:10<2888::AID-IMMU2888>3.0.CO;2-F","volume":"32","author":"C.N. Manzotti","year":"2002","unstructured":"Manzotti CN, Tipping H, Perry LC et al. Inhibition of human T-cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T-cells. Eur J Immunol 2002; 32:2888\u20132896.","journal-title":"Eur J Immunol"},{"key":"2_CR94","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/ni846","volume":"3","author":"U. Grohmann","year":"2002","unstructured":"Grohmann U, Orabona C, Fallarino F et al. CTLA-4-lg regulates tryptophan catabolism in vivo. Nat Immunol 2002; 3:1097\u20131101.","journal-title":"Nat Immunol"},{"key":"2_CR95","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.immuni.2004.09.002","volume":"21","author":"W.J. Grossman","year":"2004","unstructured":"Grossman WJ, Verbsky W, Barchet W et al. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004; 21:589\u2013601.","journal-title":"Immunity"},{"key":"2_CR96","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.4049\/jimmunol.174.4.1783","volume":"174","author":"D.C. Gondek","year":"2005","unstructured":"Gondek DC, Lu LF, Quezada SA et al. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005; 174:1783\u20131786.","journal-title":"J Immunol"},{"key":"2_CR97","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2005-11-4502","volume":"107","author":"D.M. Zhao","year":"2006","unstructured":"Zhao DM, Thornton AM, DiPaolo RJ et al. Activated CD4+CD25+ T-cells selectively kill B-Iymphocytes. Blood 2006; 107:3925\u20133932.","journal-title":"Blood"},{"key":"2_CR98","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.bbrc.2004.12.106","volume":"327","author":"B.M. Choi","year":"2005","unstructured":"Choi BM, Pae HO, Jeong YR et al. Critical role of heme oxygenase-l in Foxp3-mediated immune suppression. Biochem Biophys Res Commun 2005; 327:1066\u20131071.","journal-title":"Biochem Biophys Res Commun"},{"key":"2_CR99","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1471-4906(03)00181-9","volume":"24","author":"L.E. Otterbein","year":"2003","unstructured":"Otterbein LE, Soares MP, Yamashita K et al. Heme oxygenase-l:unleashing the protective properties of heme. Trends Immunol 2003; 24:449\u2013455.","journal-title":"Trends Immunol"},{"key":"2_CR100","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1073\/pnas.88.13.5528","volume":"88","author":"V.L. Godfrey","year":"1991","unstructured":"Godfrey VL, Wilkinson JE, Rinchik EM et al. Fatallymphoreticular disease in the scurfy (sf) mouse requires T-cells that mature in a sf thymic environment: potential model for thymic education. Proc Natl Acad Sci USA 1991; 88:5528\u20135532.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR101","first-page":"1379","volume":"138","author":"V.L. Godfrey","year":"1991","unstructured":"Godfrey VL, Wilkinson JE, Russell LB. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. AmJ Pathol 1991; 138:1379\u20131387.","journal-title":"AmJ Pathol"},{"key":"2_CR102","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"J.D. Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T-cells. Nat Immunol 2003; 4:330\u2013336.","journal-title":"Nat Immunol"},{"key":"2_CR103","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/eji.200838346","volume":"38","author":"E.N. Huter","year":"2008","unstructured":"Huter EN, Punkosdy GA, Glass DD et al. TGF-beta-induced Foxp3+ regulatory T-cells rescue scurfy mice. Eur J Immunol 2008; 38:1814\u20131821.","journal-title":"Eur J Immunol"},{"key":"2_CR104","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.188.2.287","volume":"188","author":"A.M. Thornton","year":"1998","unstructured":"Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T-cells suppress polyclonal T-cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188:287\u2013296.","journal-title":"J Exp Med"},{"key":"2_CR105","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4049\/jimmunol.167.3.1137","volume":"167","author":"C.A. Piccirillo","year":"2001","unstructured":"Piccirillo CA, Shevach EM. Cutting edge: control of CD8+ T-cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 2001; 167:1137\u20131140.","journal-title":"J Immunol"},{"key":"2_CR106","first-page":"4516","volume":"63","author":"T. Azuma","year":"2003","unstructured":"Azuma T, Takahashi T, Kunisato A et al. Human CD4+ CD25+ regulatory T-cells suppress NKT cell functions. Cancer Res 2003; 63:4516\u20134520.","journal-title":"Cancer Res"},{"key":"2_CR107","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.humimm.2004.12.006","volume":"66","author":"L.S. Taams","year":"2005","unstructured":"Taams LS, van Amelsfort JM, Tiemessen MM et al. Modulation of monocyte\/macrophage function by human CD4+CD25+ regulatory T-cells. Hum Immunol 2005; 66:222\u2013230.","journal-title":"Hum Immunol"},{"key":"2_CR108","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.4049\/jimmunol.175.7.4180","volume":"175","author":"H.W. Lim","year":"2005","unstructured":"Lim HW, Hillsamer P, Banham AH et al. Cutting Edge: Direct Suppression ofB-Cells by CD4+CD25+ Regulatory T-Cells. J Immunol 2005; 175:4180\u20134183.","journal-title":"J Immunol"},{"key":"2_CR109","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X","volume":"30","author":"L. Cederbom","year":"2000","unstructured":"Cederbom L, Hall H, Ivars F. CD4+CD25+ regulatory T-cells down-regulate costimulatory molecules on antigen-presenting cells. Eur J Immunol 2000; 30:1538\u20131543.","journal-title":"Eur J Immunol"},{"key":"2_CR110","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.4049\/jimmunol.176.3.1582","volume":"176","author":"M.J. Smyth","year":"2006","unstructured":"Smyth MJ, Teng MW, Swann J et al. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol 2006; 176:1582\u20131587.","journal-title":"J Immunol"},{"key":"2_CR111","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","volume":"12","author":"B. Salomon","year":"2000","unstructured":"Salomon B, Lenschow DJ, Rhee L et al. B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T-cells that control autoimmune diabetes. Immunity 2000; 12:431\u2013440.","journal-title":"Immunity"},{"key":"2_CR112","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.4049\/jimmunol.169.9.4712","volume":"169","author":"A.P. Kohm","year":"2002","unstructured":"Kohm AP, Carpentier PA, Anger HA et al. Cutting edge: CD4+CD25+ regulatory T-cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 2002; 169:4712\u20134716.","journal-title":"J Immunol"},{"key":"2_CR113","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1034\/j.1600-065X.2001.1820110.x","volume":"182","author":"G.C. Furtado","year":"2001","unstructured":"Furtado GC, Olivares-Villagome ZD, Curotto de Lafaille MA et al. Regulatory T-cells in spontaneous autoimmune encephalomyelitis. Immunol Rev 2001; 182:122\u2013134.","journal-title":"Immunol Rev"},{"key":"2_CR114","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","volume":"155","author":"S. Sakaguchi","year":"1995","unstructured":"Sakaguchi S, Sakaguchi N, Asano M et al. Immunologic self-tolerance maintained by activated T-cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerancecauses various autoimmune diseases. J Immunol 1995; 155:1151\u20131164.","journal-title":"J Immunol"},{"key":"2_CR115","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1034\/j.1600-065X.2001.1820115.x","volume":"182","author":"B. Singh","year":"2001","unstructured":"Singh B, Read S, Asseman C et al. Control of intestinal inflammation by regulatory T-cells. Immunol Rev 2001; 182:190\u2013200.","journal-title":"Immunol Rev"},{"key":"2_CR116","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2567.2005.02306.x","volume":"117","author":"J.H. Lee","year":"2006","unstructured":"Lee JH, Wang LC, Lin YT et al. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 2006; 117:280\u2013286.","journal-title":"Immunology"},{"key":"2_CR117","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/art.11063","volume":"48","author":"M.E. Morgan","year":"2003","unstructured":"Morgan ME, Sutmuller RP, Witteveen HJ et al. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum 2003; 48: 1452\u20131460.","journal-title":"Arthritis Rheum"},{"key":"2_CR118","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4049\/jimmunol.160.3.1212","volume":"160","author":"E. Suri-Payer","year":"1998","unstructured":"Suri-Payer E, Amar AZ, Thornton AM et al. CD4+CD2S+ T-cells inhibit both the induction and effector function of autoreactive T-cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998; 160:1212\u20131218.","journal-title":"J Immunol"},{"key":"2_CR119","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0041-1345(00)01956-4","volume":"33","author":"J. Chen","year":"2001","unstructured":"Chen J, Huoam C, Plain K et al. CD4(+), CD2S(+) T-cells as regulators of alloimmune responses. Transplant Proc 2001; 33:163\u2013164.","journal-title":"Transplant Proc"},{"key":"2_CR120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nri1027","volume":"3","author":"K.J. Wood","year":"2003","unstructured":"Wood KJ, Sakaguchi S. Regulatory T-cells in transplantation tolerance. Nat Rev Immunol 2003; 3:199\u2013210.","journal-title":"Nat Rev Immunol"},{"key":"2_CR121","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0966-3274(03)00046-7","volume":"11","author":"S.F. Oluwole","year":"2003","unstructured":"Oluwole SF, Oluwole OO, DePaz HA et al. CD4+CD2S+ regulatory T-cells mediate acquired transplant tolerance. Transpl Immunol 2003; 11:287\u2013293.","journal-title":"Transpl Immunol"},{"key":"2_CR122","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature01152","volume":"420","author":"Y. Belkaid","year":"2002","unstructured":"Belkaid Y, Piccirillo CA, Mendez S et al. CD4+CD2S+ regulatory T-cells control Leishmania major persistence and immunity. Nature 2002; 420:502\u2013507.","journal-title":"Nature"},{"key":"2_CR123","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/1521-4141(200205)32:5<1282::AID-IMMU1282>3.0.CO;2-#","volume":"32","author":"S. Hori","year":"2002","unstructured":"Hori S, Carvalho TL, Demengeot J. CD2S+CD4+ regulatory T-cells suppress CD4+ T-cell-mediated pulmonary hyperinAammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 2002; 32:1282\u20131291.","journal-title":"Eur J Immunol"},{"key":"2_CR124","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.0105-2896.2006.00412.x","volume":"212","author":"B.T. Rouse","year":"2006","unstructured":"Rouse BT, Sarangi PP, Suvas S. Regulatory T-cells in virus infections. Immunol Rev 2006; 212:272\u2013286.","journal-title":"Immunol Rev"},{"key":"2_CR125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1084\/jem.20020556","volume":"196","author":"M.C. Kullberg","year":"2002","unstructured":"Kullberg MC, Jankovic D, Gorelick PL et al. Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med 2002; 196:505\u2013515.","journal-title":"J Exp Med"},{"key":"2_CR126","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jss.2004.10.004","volume":"124","author":"H. Kawaida","year":"2005","unstructured":"Kawaida H, Kono K, Takahashi A et al. Distribution of CD4+CD2Shigh regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer. J Surg Res 2005; 124:151\u2013157.","journal-title":"J Surg Res"},{"key":"2_CR127","first-page":"4766","volume":"61","author":"E.Y. Woo","year":"2001","unstructured":"Woo EY, Chu CS, Goletz TJ et al. Regulatory CD4(+)CD2S(+) T-cells in tumors from patients with early-stage nonsmall cell lung cancer and late-stage ovarian cancer. Cancer Res 2001; 61:4766\u20134772.","journal-title":"Cancer Res"},{"key":"2_CR128","first-page":"5267","volume":"62","author":"R. Somasundaram","year":"2002","unstructured":"Somasundaram R, Jacob L, Swoboda R et al. Inhibition of cytolytic T-Iymphocyte proliferation by autologous CD4+\/CD2S+ regulatory T-cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta. Cancer Res 2002; 62:5267\u20135272.","journal-title":"Cancer Res"},{"key":"2_CR129","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.169.5.2756","volume":"169","author":"U.K. Liyanage","year":"2002","unstructured":"Liyanage UK, Moore TT, Joo HG et al. Prevalence of regulatory T-cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002; 169:2756\u20132761.","journal-title":"J Immunol"},{"key":"2_CR130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/eji.200324181","volume":"34","author":"F. Ghiringhelli","year":"2004","unstructured":"Ghiringhelli F, Larmonier N, Schmitt E et al. CD4+CD2S+ regulatory T-cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur J Immunol 2004; 34:336\u2013344.","journal-title":"Eur J Immunol"},{"key":"2_CR131","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2003.09.020","volume":"92","author":"A. Fattorossi","year":"2004","unstructured":"Fattorossi A, Battaglia A, Ferrandina G et al. Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients. Gynecol Oncol 2004; 92:106\u2013115.","journal-title":"Gynecol Oncol"},{"key":"2_CR132","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/cncr.11618","volume":"98","author":"T. Sasada","year":"2003","unstructured":"Sasada T, Kimura M, Yoshida Y et al. CD4+CD2S+ regulatory T-cells in patients with gastrointestinal malignancies: possible involvement of regulatory T-cells in disease progression. Cancer 2003; 98:1089\u20131099.","journal-title":"Cancer"},{"key":"2_CR133","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.bjc.6602407","volume":"92","author":"C. Schaefer","year":"2005","unstructured":"Schaefer C, Kim GG, Albers A et al. Characteristics of CD4+CD2S+ regulatory T-cells in the peripheral circulation of patients with head and neck cancer. Br J Cancer 2005; 92:913\u2013920.","journal-title":"Br J Cancer"},{"key":"2_CR134","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.20644","volume":"41","author":"E. Unitt","year":"2005","unstructured":"Unitt E, Rushbrook SM, Marshall A et al. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 2005; 41:722\u2013730.","journal-title":"Hepatology"},{"key":"2_CR135","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","volume":"105","author":"C.L. Berger","year":"2005","unstructured":"Berger CL, Tigelaar R, Cohen J et al. Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Blood 2005; 105:1640\u20131647.","journal-title":"Blood"},{"key":"2_CR136","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2003-07-2594","volume":"103","author":"N.A. Marshall","year":"2004","unstructured":"Marshall NA, Christie LE, Munro LR et al. Immunosuppressive regulatory T-cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 2004; 103:1755\u20131762.","journal-title":"Blood"},{"key":"2_CR137","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood-2005-02-0642","volume":"106","author":"M. Beyer","year":"2005","unstructured":"Beyer M, Kochanek M, Darabi K et al. Reduced frequencies and suppressive function of CD4+CD25hi regulatory T-cells in patients with chronic lymphocytic leukemia after therapy with Audarabine. Blood 2005; 106:2018\u20132025.","journal-title":"Blood"},{"key":"2_CR138","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.4049\/jimmunol.180.8.5163","volume":"180","author":"G.Y. Chen","year":"2008","unstructured":"Chen GY, Chen C, Wang L et al. Cutting edge: Broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inAammatory diseases following in vivo depletion of FoxP3-expressing cells. J Immunol 2008; 180:5163\u20135166.","journal-title":"J Immunol"},{"key":"2_CR139","first-page":"3765","volume":"117","author":"T. Zuo","year":"2007","unstructured":"Zuo T, Liu R, Zhang H et al. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2. J Clin Invest 2007; 117:3765\u20133773.","journal-title":"J Clin Invest"},{"key":"2_CR140","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1158\/0008-5472.CAN-07-5664","volume":"68","author":"L.M. Ebert","year":"2008","unstructured":"Ebert LM, Tan BS, Browning J et al. The regulatory T-cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res 2008; 68:3001\u20133009.","journal-title":"Cancer Res"},{"key":"2_CR141","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1479-5876-6-19","volume":"6","author":"V. Karanikas","year":"2008","unstructured":"Karanikas V, Speletas M, Zamanakou M et al. Foxp3 expression in human cancer cells. J Transl Med 2008; 6:19.","journal-title":"J Transl Med"},{"key":"2_CR142","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.immuni.2007.04.017","volume":"27","author":"T. Yamaguchi","year":"2007","unstructured":"Yamaguchi T, Hirota K, Nagahama K et al. Control of immune responses by antigen-specific regulatory T-cells expressing the folate receptor. Immunity 2007; 27:145\u2013159.","journal-title":"Immunity"}],"container-title":["Advances in Experimental Medicine and Biology","Forkhead Transcription Factors"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4419-1599-3_2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T17:40:15Z","timestamp":1711647615000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4419-1599-3_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9781441915986","9781441915993"],"references-count":142,"URL":"https:\/\/doi.org\/10.1007\/978-1-4419-1599-3_2","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}